Cost-Effectiveness of Gene-Specific Prevention for Ovarian and Breast Cancer

Xia Wei,Li Sun,Eric Slade,Caitlin T. Fierheller,Samuel Oxley,Ashwin Kalra,Jacqueline Sia,Michail Sideris,W. Glenn McCluggage,Nathan Bromham,Katharina Dworzynski,Adam N. Rosenthal,Adam Brentnall,Stephen Duffy,D. Gareth Evans,Li Yang,Rosa Legood,Ranjit Manchanda

DOI: https://doi.org/10.1001/jamanetworkopen.2023.55324

2024-02-10

JAMA Network Open

Abstract:This economic evaluation estimates the cost-effectiveness of prevention strategies for ovarian and breast cancer among individuals with pathogenic variants in cancer susceptibility genes BRCA1, BRCA2, PALB2, RAD51C, RAD51D, and BRIP1.

medicine, general & internal